Spots Global Cancer Trial Database for carboplatin
Every month we try and update this database with for carboplatin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Efficacy/Safety of Imprime PGG With Cetuximab & Paclitaxel/Carboplatin Therapy in Pts With Untreated Advanced Non-Small Cell Lung Cancer | NCT00874848 | NSCLC | Imprime PGG Inj... Cetuximab Paclitaxel Carboplatin | 18 Years - 75 Years | HiberCell, Inc. | |
| An Investigational Immuno-therapy Study of Nivolumab Given After Surgery in Non-Small Cell Lung Cancer (NSCLC) Participants With Minimal Residual Disease | NCT03770299 | Non-Small Cell ... Non-Small-Cell ... Circulating Tum... | Nivolumab Vinorelbine Gemcitabine Docetaxel Pemetrexed Cisplatin Carboplatin Paclitaxel Observation | 18 Years - | Bristol-Myers Squibb | |
| A Study of Bevacizumab With Carboplatin and Paclitaxel Chemotherapy for the First-Line Treatment of Patients With Metastatic Melanoma | NCT00434252 | Melanoma | bevacizumab carboplatin paclitaxel placebo | 18 Years - | Genentech, Inc. | |
| Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal Cancer | NCT02389751 | Gastroesophagea... Malignant Neopl... Malignant Neopl... Stage IIA Esoph... Stage IIB Esoph... Stage IIIA Esop... Stage IIIB Esop... Stage IIIC Esop... | Carboplatin Ganetespib Paclitaxel Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | NCT00002623 | Lung Cancer | carboplatin cisplatin conventional su... radiation thera... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | NCT01767675 | Ovarian Cancer Fallopian Tubes... Peritoneal Canc... | Secondary Cytor... Carboplatin Hyp... platinum-based ... platinum-based ... | 21 Years - | Memorial Sloan Kettering Cancer Center | |
| Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer | NCT00214058 | Ovarian Carcino... Primary Periton... | Carboplatin Docetaxel | 18 Years - | University of Wisconsin, Madison | |
| TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer | NCT01493505 | Fallopian Tube ... Ovarian Cancer Peritoneal Canc... | AMG 386 Paclitaxel AMG 386 Placebo Carboplatin | 18 Years - | Amgen | |
| S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00661193 | Lung Cancer | carboplatin erlotinib hydro... paclitaxel | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors | NCT00815945 | Mesenchymal Tum... Carcinosarcoma Leiomyosarcoma | PegLiposomal Do... Carboplatin | 18 Years - | AGO Study Group | |
| Phase II Study Evaluating the Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Chemotherapy as First-line Treatment for Participants With Advanced Triple Negative Breast Cancer | NCT05809895 | Triple Negative... | Ociperlimab Tislelizumab Paclitaxel Nab-paclitaxel Carboplatin Placebo Pembrolizumab Gemcitabine | 18 Years - | Novartis | |
| Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2). | NCT04472429 | Squamous Cell C... | carboplatin paclitaxel retifanlimab | 18 Years - | Incyte Corporation | |
| Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway Signaling | NCT01868022 | Neoplasms | GSK3052230 paclitaxel carboplatin docetaxel pemetrexed cisplatin | 18 Years - | GlaxoSmithKline | |
| Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer | NCT04223856 | Urothelial Canc... | Enfortumab vedo... Pembrolizumab Cisplatin Carboplatin Gemcitabine | 18 Years - | Astellas Pharma Inc | |
| Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer | NCT02621398 | Stage II Non-Sm... Stage IIIA Non-... Stage IIIB Non-... | 3-Dimensional C... Carboplatin Intensity-Modul... Laboratory Biom... Paclitaxel Pembrolizumab | 18 Years - | Rutgers, The State University of New Jersey | |
| Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS) | NCT00669747 | Ductal Carcinom... | Carboplatin i.d... Carboplatin i.d... Normal Saline | 18 Years - | Windy Hill Medical, Inc. | |
| A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation | NCT05789082 | Non-Small Cell ... | Divarasib Pembrolizumab Carboplatin Cisplatin Pemetrexed | 18 Years - | Hoffmann-La Roche | |
| Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer | NCT02810457 | Carcinoma, Non-... | FKB238 (bevaciz... Avastin (bevaci... Paclitaxel Carboplatin | 18 Years - | Centus Biotherapeutics Limited | |
| A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Untreated, Advanced Non-Small Cell Lung Cancer | NCT01268059 | Non-small Cell ... | Carboplatin Paclitaxel MEDI-575 | 18 Years - 99 Years | MedImmune LLC | |
| Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer | NCT00151034 | Urologic Neopla... | Trastuzumab Paclitaxel Carboplatin Gemcitabine | 18 Years - | University of Michigan Rogel Cancer Center | |
| Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes | NCT06439225 | Metastatic Cast... Metastatic Pros... | Docetaxel Carboplatin | 18 Years - | Canadian Cancer Trials Group | |
| A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors | NCT06057038 | Malignant Solid... | GEN1042 Pembrolizumab Cisplatin Carboplatin 5-Fluorouracil | 18 Years - | Genmab | |
| Dose Escalation Study of BIBF 1120 in Patients With Advanced Gynaecological Malignancies | NCT02182245 | Genital Neoplas... | BIBF 1120 Paclitaxel Carboplatin | 18 Years - | Boehringer Ingelheim | |
| Phase II Study Evaluating the Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Chemotherapy as First-line Treatment for Participants With Advanced Triple Negative Breast Cancer | NCT05809895 | Triple Negative... | Ociperlimab Tislelizumab Paclitaxel Nab-paclitaxel Carboplatin Placebo Pembrolizumab Gemcitabine | 18 Years - | Novartis | |
| Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic Melanoma | NCT01009515 | Melanoma | Paclitaxel, car... | 18 Years - | New Mexico Cancer Care Alliance | |
| Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer | NCT00714246 | Non Small Cell ... | Bortezomib Carboplatin Docetaxel | 18 Years - 90 Years | Milton S. Hershey Medical Center | |
| A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) | NCT04222972 | RET-fusion Non ... Lung Neoplasm Carcinoma, Non-... Respiratory Tra... Thoracic Neopla... Neoplasms by Si... Neoplasms Lung Diseases Respiratory Tra... Carcinoma, Bron... Bronchial Disea... Head and Neck N... Adenocarcinoma Carcinoma Neoplasms by Hi... Neoplasms, Germ... Neoplasms, Nerv... | Pralsetinib Carboplatin Cisplatin Pemetrexed Pembrolizumab Gemcitabine Paclitaxel Nab-Paclitaxel | 18 Years - | Hoffmann-La Roche | |
| Adavosertib Plus Chemotherapy in Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | NCT02272790 | Ovarian, Fallop... | Adavosertib Paclitaxel Carboplatin Gemcitabine PLD | 18 Years - 130 Years | AstraZeneca | |
| Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer | NCT04592237 | Aggressive Vari... Castration-Resi... Metastatic Pros... Metastatic Pros... Metastatic Pros... Stage IV Prosta... | Cabazitaxel Carboplatin Cetrelimab Niraparib | 18 Years - | M.D. Anderson Cancer Center | |
| A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma | NCT04166409 | Low Grade Astro... Low Grade Gliom... Metastatic Low ... Metastatic Low ... | Biospecimen Col... Carboplatin Magnetic Resona... Quality-of-Life... Questionnaire A... Selumetinib Sul... Vincristine Sul... | 2 Years - 21 Years | National Cancer Institute (NCI) | |
| Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer | NCT00063999 | Recurrent Uteri... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri... | Carboplatin Cisplatin Doxorubicin Hyd... Filgrastim Laboratory Biom... Paclitaxel Pegfilgrastim Quality-of-Life... | 18 Years - | GOG Foundation | |
| Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian Cancer | NCT05794659 | Advanced Ovaria... | AST-201 Paclitaxel Carboplatin Placebo rhuGM-CSF(Granu... | 18 Years - | Aston Sci. Inc. | |
| Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal Cancer | NCT00193141 | Esophagus Cance... | Paclitaxel Carboplatin 5-Fluorouracil | 18 Years - | SCRI Development Innovations, LLC | |
| Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT00553462 | Lung Cancer | carboplatin erlotinib hydro... paclitaxel albu... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) - China Extension Study | NCT04865289 | Endometrial Neo... | Lenvatinib Pembrolizumab Paclitaxel Carboplatin | 18 Years - | Merck Sharp & Dohme LLC | |
| Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC) | NCT01069328 | Carcinoma, Non-... Lung Cancer | Nexavar (Sorafe... Nexavar (Sorafe... Bevacizumab Bevacizumab Bevacizumab Bevacizumab Paclitaxel Carboplatin | 18 Years - | Bayer | |
| Chemotherapy in Treating Children With Liver Cancer | NCT00003912 | Liver Cancer | carboplatin cisplatin doxorubicin hyd... conventional su... | - 16 Years | National Cancer Institute (NCI) | |
| AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer | NCT05377658 | Non-small Cell ... | AK104 Albumin-Bound P... Carboplatin | 18 Years - 75 Years | Henan Cancer Hospital | |
| Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS) | NCT00204646 | Sarcoma, Soft T... | Adriamycin Ifosfamide Etoposide Carboplatin | 18 Years - 65 Years | University Hospital Tuebingen | |
| Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC) | NCT02934503 | Small Cell Lung... | Pembrolizumab Cisplatin Carboplatin Etoposide Radiation thera... | 19 Years - | NYU Langone Health | |
| Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer | NCT03367871 | Cervical Cancer | Pembrolizumab Paclitaxel Cisplatin Carboplatin Bevacizumab | 18 Years - | University of Miami | |
| Trial Comparing Niraparib-bevacizumab-Dostarlimab and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian Cancer | NCT03806049 | Ovarian Cancer | Niraparib Bevacizumab TSR042 Carboplatin Paclitaxel | 18 Years - 100 Years | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | |
| Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO) | NCT04776447 | Lung Diseases Carcinoma, Non-... Stage IIIA Non-... Stage IIIB Non-... Respiratory Tra... Carcinoma Bronc... Thoracic Neopla... | Carboplatin Placlitaxel Atezolizumab | 18 Years - 75 Years | Fundación GECP | |
| Combination Chemotherapy in Treating Children With Neuroblastoma | NCT00003093 | Neuroblastoma | filgrastim sargramostim carboplatin cyclophosphamid... doxorubicin hyd... etoposide conventional su... neoadjuvant the... | - 20 Years | Children's Oncology Group | |
| A Study Comparing Two Carboplatin Containing Regimens for Children and Young Adults With Previously Untreated Low Grade Glioma | NCT02455245 | Low Grade Gliom... | Carboplatin Vincristine | - 21 Years | Ann & Robert H Lurie Children's Hospital of Chicago | |
| Itraconazole in Advanced Ovarian Cancer | NCT05591560 | Ovarian Carcino... | Itraconazole ca... Placebo | 18 Years - 65 Years | Tanta University | |
| Effect of Pembrolizumab With or Without Carboplatin and Paclitaxel on Immune Response in Patients With Recurrent or Stage IIIB-IV Non-small Cell Lung Cancer | NCT02581943 | Recurrent Non-S... Stage IIIB Non-... Stage IV Non-Sm... | Carboplatin Laboratory Biom... Paclitaxel Pembrolizumab Quality-of-Life... | 18 Years - | Wake Forest University Health Sciences | |
| Sintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced or Metastatic Squamous NSCLC | NCT03629925 | Squamous NSCLC | Sintilimab Gemcitabine Cisplatin Placebo Carboplatin | 18 Years - 75 Years | Innovent Biologics (Suzhou) Co. Ltd. | |
| Carboplatin-Paclitaxel-Bevacizumab vs Carbo-Pacli-Beva-Rucaparib vs Carbo-Pacli-Ruca, Selected According to HRD Status, in Patients With Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer, Preceded by a Phase I Dose Escalation Study on Ruca-Beva Combination | NCT03462212 | Advanced (Stage... | Carboplatin Paclitaxel Bevacizumab Rucaparib | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
| RAD001 in Combination With Cetuximab and Cisplatin in Recurrent and Metastatic SCCHN | NCT01009346 | Head and Neck C... | RAD001 Cetuximab Cisplatin Carboplatin | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| A Phase 1-2 XIAP Antisense AEG35156 With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer | NCT00558922 | Carcinoma, Non-... | AEG35156 | 18 Years - | Aegera Therapeutics | |
| Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery | NCT00110019 | Mucosal Melanom... Recurrent Melan... Stage IIIA Skin... Stage IIIB Skin... Stage IIIC Skin... Stage IV Skin M... | Carboplatin Laboratory Biom... Paclitaxel Pharmacological... Placebo Sorafenib Tosyl... | 18 Years - | National Cancer Institute (NCI) | |
| Ph II Adjuvant Carboplatin/Docetaxel in Curatively Resected Stage I-IIIA NSCLC | NCT00280735 | Lung Cancer | carboplatin docetaxel | 18 Years - 120 Years | UNC Lineberger Comprehensive Cancer Center | |
| Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study) | NCT01555710 | Extensive-Stage... | Carboplatin Palifosfamide-t... Etoposide Carboplatin | 18 Years - | Alaunos Therapeutics | |
| Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma | NCT02782754 | Intracranial Ge... | Carboplatin Etoposide Cyclophosphamid... Bleomycin Reduced dose of... | 3 Years - 30 Years | Samsung Medical Center | |
| A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC | NCT03134872 | Lung Neoplasms Carcinoma, Non-... Respiratory Tra... Thoracic Neopla... Lung Diseases Respiratory Tra... Neoplasms by Si... Neoplasm, Bronc... Carcinoma, Bron... | SHR-1210 Carboplatin Pemetrexed | 18 Years - 70 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer | NCT01413750 | Stage IIIA Non-... Stage IIIB Non-... Stage IV Non-Sm... | Paclitaxel Carboplatin Vorinostat Placebo Laboratory Biom... | 18 Years - | National Cancer Institute (NCI) | |
| APatinib Plus Chemotherapy vErsus Chemotherapy As First-line Treatment for Advanced NSCLC | NCT03164694 | Lung Cancer | Apatinib Pemetrexed Carboplatin | 18 Years - 75 Years | Sun Yat-sen University | |
| Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer | NCT03158129 | Stage I Lung No... Stage IA Lung N... Stage IB Lung N... Stage II Lung N... Stage IIA Lung ... Stage IIB Lung ... Stage IIIA Lung... | Carboplatin Cisplatin Docetaxel Ipilimumab Nivolumab Pemetrexed | 18 Years - | M.D. Anderson Cancer Center | |
| High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors | NCT00936936 | Testicular Canc... | Gemcitabine Docetaxel Melphalan Carboplatin Mesna Ifosfamide Etoposide Stem Cell Trans... | 12 Years - 65 Years | M.D. Anderson Cancer Center | |
| Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer | NCT00753909 | Non Small Cell ... | Carboplatin Bevacizumab Paclitaxel | 18 Years - | Hellenic Oncology Research Group | |
| Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer | NCT00104793 | Lung Cancer | carboplatin irinotecan hydr... | 18 Years - | National Cancer Institute (NCI) | |
| A Phase 1-2 XIAP Antisense AEG35156 With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer | NCT00558922 | Carcinoma, Non-... | AEG35156 | 18 Years - | Aegera Therapeutics | |
| Pulsed Dose Chemotherapy Plus Pembrolizumab in Recurrent/Metastatic HNSCC | NCT06052839 | Recurrent/Metas... | Pembrolizumab Carboplatin Paclitaxel | 18 Years - | University of Pittsburgh | |
| Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation | NCT05806515 | Prostate Adenoc... Stage IIIB Pros... Stage IIIC Pros... | Biospecimen Col... Carboplatin Chest Radiograp... Computed Tomogr... Magnetic Resona... PSMA PET Scan Surgical Proced... | 18 Years - | SWOG Cancer Research Network | |
| Intraperitoneal Paclitaxel and Carboplatin in the Treatment of Women With Carcinoma of Mullerian Origin | NCT00181701 | Ovarian Carcino... | Paclitaxel Carboplatin | 18 Years - | Massachusetts General Hospital | |
| Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer | NCT05415709 | Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Ovarian Endomet... Ovarian Mucinou... Ovarian Serous ... Primary Periton... Primary Periton... Stage III Fallo... Stage III Ovari... Stage III Prima... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIA1 Fal... Stage IIIA1 Ova... Stage IIIA2 Fal... Stage IIIA2 Ova... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IVA Fallo... Stage IVA Ovari... Stage IVA Prima... Stage IVB Fallo... Stage IVB Ovari... Stage IVB Prima... | Carboplatin Cisplatin Cytoreductive S... Hyperthermic In... Paclitaxel Quality-of-Life... Questionnaire A... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval | NCT00657878 | Ovarian Cancer | stealth liposom... carboplatin paclitaxel Topotecan Gemcitabine | - | National Cancer Institute, Naples | |
| Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers | NCT01523678 | Ovarian Cancer Endometrial Can... Uterine Cervica... | Filgrastim Paclitaxel Carboplatin | 18 Years - | Belgian Gynaecological Oncology Group | |
| Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | NCT01074411 | Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Ovarian Brenner... Ovarian Clear C... Ovarian Clear C... Ovarian Endomet... Ovarian Mucinou... Ovarian Mucinou... Ovarian Seromuc... Ovarian Serous ... Ovarian Serous ... Ovarian Transit... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... Undifferentiate... Undifferentiate... | Bortezomib Carboplatin Laboratory Biom... Pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| MPDL3280A With Chemoradiation for Lung Cancer | NCT02525757 | Lung Cancer Non-Small Cell ... | MPDL3280A Carboplatin Paclitaxel Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| MONET1-MOtesanib NSCLC Efficacy and Tolerability Study | NCT00460317 | Non-Small Cell ... | AMG 706 placebo paclitaxel carboplatin | 18 Years - | Amgen | |
| Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer | NCT03382561 | Extensive Stage... Recurrent Lung ... | Carboplatin Cisplatin Etoposide Nivolumab | 18 Years - | National Cancer Institute (NCI) | |
| Phase Ib/II Study of Carboplatin + M6620 + Avelumab in PARPi-resistant Ovarian Cancer | NCT03704467 | Ovarian Cancer | M6620 Avelumab Carboplatin | 18 Years - | EMD Serono | |
| ICON8: Weekly Chemotherapy in Ovarian Cancer | NCT01654146 | Ovarian Cancer | Carboplatin Carboplatin Paclitaxel Paclitaxel | 18 Years - | Medical Research Council | |
| Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC | NCT05800340 | Non-Small Cell ... RET Driver Muta... BRAF V600 Mutat... Erb-B2 Receptor... MET Amplificati... MET Exon 14 Ski... | Toripalimab Nab paclitaxel Pemetrexed Carboplatin | 18 Years - | Guangdong Provincial People's Hospital | |
| Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Participants With Solid Tumors | NCT01862328 | Solid Tumors | MLN4924 Paclitaxel Gemcitabine Docetaxel Carboplatin | 18 Years - | Takeda | |
| ZD1839 (Iressa™) and Concurrent Chemo-Radiation in Patients With Locally Advanced Non Small Cell Lung Cancer | NCT00252798 | Non Small Cell ... | Gefitinib Carboplatin Paclitaxel Radiation | 18 Years - | AstraZeneca | |
| Efficacy and Safety Study of Concurrent Chemoradiation Therapy to Treat Locally Advanced Cervical Cancer | NCT01461772 | Cervical Cancer | Radiation thera... Carboplatin Cisplatin | 20 Years - 75 Years | Asan Medical Center | |
| S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00085501 | Lung Cancer | cetuximab carboplatin paclitaxel | 18 Years - | SWOG Cancer Research Network |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
